222

Exxel Pharma’s Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Exxel Pharma to Participate in a “New to Virtual Investor” Segment
Exxel’s CSO Daniele Piomelli receives Entrepreneurial Leader of the Year award from UC Irvine (UCI) Beall Applied Innovation
NEW YORK TIMES: At 71, She’s Never Felt Pain or Anxiety. Now Scientists Know Why.
University of Malta scientists speak of ‘safe way to block seizures with endocannabinoids’